Stochastic model of metastases formation
- PMID: 963169
Stochastic model of metastases formation
Abstract
A mathematical model is developed to describe the dynamics of the hematogenous metastatic process to the lung from a solid tumor growing in a peripheral body site. The accumulation of tumor cell clumps of various sizes in the pulmonary circulation and the formation of metastatic foci are described by a non-homogeneous, two-dimensional Markov process. An analytical solution is found for the special case of metastases produced by the intravenous injection of tumor cell clumps. The system is decoupled experimentally to determine the time-varying entrance rate of tumor cell clumps into the circulation from a growing fibrosarcoma and the number of metastatic foci produced by the intravenous injection of tumor clumps. Model validation is based on comparisons of model simulations with data for the development of metastatic foci and the probability of cure following tumor excision. The model is used to simulate hypothetical therapy to prevent tumor metastases.
Similar articles
-
The significance of hematogenous tumor cell clumps in the metastatic process.Cancer Res. 1976 Mar;36(3):889-94. Cancer Res. 1976. PMID: 1253177
-
In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes.J Natl Cancer Inst. 1981 Jan;66(1):183-9. J Natl Cancer Inst. 1981. PMID: 6935459
-
Effect of protein kinase C activating tumor promoters on metastases formation by fibrosarcoma cells.Invasion Metastasis. 1991;11(1):14-24. Invasion Metastasis. 1991. PMID: 2061000
-
Modeling growth kinetics and statistical distribution of oligometastases.Semin Radiat Oncol. 2006 Apr;16(2):111-9. doi: 10.1016/j.semradonc.2005.12.006. Semin Radiat Oncol. 2006. PMID: 16564446 Review.
-
Cellular interactions in the metastatic process.Prog Clin Biol Res. 1976;9:237-44. Prog Clin Biol Res. 1976. PMID: 799800 Review.
Cited by
-
Dormancy in breast cancer.Breast Cancer (Dove Med Press). 2012 Dec 5;4:183-91. doi: 10.2147/BCTT.S26431. Breast Cancer (Dove Med Press). 2012. PMID: 24367205 Free PMC article. Review.
-
Disease progression model of 4T1 metastatic breast cancer.J Pharmacokinet Pharmacodyn. 2020 Feb;47(1):105-116. doi: 10.1007/s10928-020-09673-5. Epub 2020 Jan 22. J Pharmacokinet Pharmacodyn. 2020. PMID: 31970615
-
Chronic arsenic exposure induces malignant transformation of human HaCaT cells through both deterministic and stochastic changes in transcriptome expression.Toxicol Appl Pharmacol. 2024 Mar;484:116865. doi: 10.1016/j.taap.2024.116865. Epub 2024 Feb 17. Toxicol Appl Pharmacol. 2024. PMID: 38373578 Free PMC article.
-
Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics.Cancer Res. 2023 Aug 15;83(16):2775-2789. doi: 10.1158/0008-5472.CAN-22-2558. Cancer Res. 2023. PMID: 37205789 Free PMC article.
-
Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial.BMC Cancer. 2013 Oct 15;13:480. doi: 10.1186/1471-2407-13-480. BMC Cancer. 2013. PMID: 24128322 Free PMC article. Clinical Trial.